Dechra Pharmaceuticals
Dechra Pharmaceuticals plc is a business involved in the development and marketing of veterinary products based in Northwich, England. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
![]() | |
Type | Public |
---|---|
LSE: DPH FTSE 100 component | |
Industry | Pharmaceuticals |
Founded | 1997 |
Headquarters | Northwich, England, UK |
Key people | Alison Platt, (Chairman) Ian Page, (CEO) |
Revenue | ![]() |
![]() | |
![]() | |
Number of employees | 2,036 (2022)[1] |
Website | www |
History
The Company was founded in 1997 by way of a management buy-out from Lloyds Chemists.[2] It was first listed on the London Stock Exchange in 2000.[2] In 2007 it bought VetXX, a Danish veterinary products business, for £62 million.[3] In 2010 it purchased Florida-based DermaPet for US$64 million[4] and Sussex-based Genitrix for £5 million.[5]
It sold its veterinary services business to US-firm, Patterson Companies, for £87.5m in July 2013 in order to focus on its higher margin manufacturing business.[6]
In June 2023, the private equity organisation, EQT Partners, made an agreed takeover offer for the company which valued the company at £4.5 billion.[7]
Operations
The company sells various pharmaceuticals for common pets and farm animals – mainly for dogs, cats, equine and food producing animals. Their notable products include Vetoryl, a medicine for Cushing's disease in dogs, and Felimazole, medicine for hyperthyroidism in cats. The company is organised into two regional divisions: European Pharmaceuticals and U.S. Pharmaceuticals.[8]
References
- "Annual Report 2022" (PDF). Dechra Pharmaceuticals. Retrieved 16 February 2023.
- "Montague Private Equity announces sale of VetXX".
- "Dechra Pharma to buy VetXX for 61.7 mln stg". Reuters. 12 December 2007. Retrieved 28 March 2015.
- "Dechra Pharma buys DermaPet for US$64 mln". Proactive Investors. 22 October 2010. Retrieved 1 March 2020.
- "Dechra acquires Sussex-based Genitrix in a £5.4m deal". Business Live. 1 December 2010. Retrieved 1 March 2020.
- "Dechra sells up". Investors Chronicle. 11 July 2013. Retrieved 16 March 2014.
- "Dechra Pharmaceuticals agrees £4.5bn takeover deal with Swedish private equity firm". Business Live. 2 June 2023. Retrieved 10 July 2023.
- "Dechra Pharmaceuticals PLC". dechraplc.com. Retrieved 28 March 2015.